Assessment of Suprachoroidal Injection of Triamcinolone Acetonide in Cases of Diabetic Macular Edema

Código QR

Assessment of Suprachoroidal Injection of Triamcinolone Acetonide in Cases of Diabetic Macular Edema

Background: Diabetic retinopathy [DR] remains one of the main causes of visual reduction in the world. The visual reduction in patients with DR is usually due to diabetic macular edema [DME].Suprachoroidal triamcinolone acetonide injection is a new effective modality used for the management of diabe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mahmoud Samy Yousef, Yonis Abd Elhafez, Mohamed Farag
Formato:	article
Lenguaje:	EN
Publicado:	Al-Azhar University, Faculty of Medicine (Damietta) 2021
Materias:	keywords: diabetic macular edema triamcinolone acetonide suprachoroidal space optical coherence tomography Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/d8ba62128e7a426cbe73606d8c649936
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Managing solar retinopathy with suprachoroidal triamcinolone acetonide injection in a young girl: a case report
por: Ameen Marashi, et al.
Publicado: (2021)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
por: Tsai MJ, et al.
Publicado: (2018)

Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide Visualization
por: Wallsh J, et al.
Publicado: (2021)

Update on corticosteroids for diabetic macular edema
por: Schwartz SG, et al.
Publicado: (2016)

Primary treatment of diabetic macular edema
por: Tushar M Ranchod, et al.
Publicado: (2009)

Outcomes of Epiretinal Membrane Removal Utilizing Triamcinolone Acetonide Visualization and Internal Limiting Membrane Forceps
por: Asahi MG, et al.
Publicado: (2020)

Transdermal permeability of triamcinolone acetonide lipid nanoparticles
por: Qin ZM, et al.
Publicado: (2019)

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
por: Saedon H, et al.
Publicado: (2017)

Comparison of Posterior Hyaloid Assessment Using Preoperative Optical Coherence Tomography and Intraoperative Triamcinolone Acetonide Staining During Vitrectomy
por: Albabtain B, et al.
Publicado: (2021)

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
por: Ume Sughra, et al.
Publicado: (2021)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
por: Adán A, et al.
Publicado: (2020)

Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
por: Javier Obis, et al.
Publicado: (2021)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
por: Massin P, et al.
Publicado: (2016)

Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
por: Mushtaq B, et al.
Publicado: (2021)

The suprachoroidal space: from potential space to a space with potential
por: Moisseiev E, et al.
Publicado: (2016)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
por: Coelho J, et al.
Publicado: (2019)

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
por: Zarranz-Ventura J, et al.
Publicado: (2020)

Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE
por: Elbarky AM
Publicado: (2020)

Vitrectomy for center-involved diabetic macular edema
por: Browning DJ, et al.
Publicado: (2016)

Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
por: Zarranz-Ventura J, et al.
Publicado: (2020)

Subfoveal choroidal thickness in diabetic macular edema
por: Mohamed DM, et al.
Publicado: (2019)

Macular edema in siliconized eyes
por: Kaya A, et al.
Publicado: (2016)

Analysis of the central zone of the retina in patients with diabetic macular edema
por: Mukharram Muhtaramovich Bikbov, et al.
Publicado: (2015)

Challenges in Diabetic Macular Edema Management: An Expert Consensus Report
por: Udaondo P, et al.
Publicado: (2021)

Pseudophakic cystoid macular edema: update 2016
por: Grzybowski A, et al.
Publicado: (2016)

CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC MACULAR EDEMA
por: Amash Aqil, et al.
Publicado: (2021)

Modern aproaches to diabetic macular edema diagnosticks
por: A. V. Doga, et al.
Publicado: (2020)

Suprachoroidal Gas: A Rare Complication of Intravitreal Injection of Perfluoropropane
por: Liana Dedina, et al.
Publicado: (2021)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
por: Andrzej Grzybowski, et al.
Publicado: (2021)

Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas
por: Alsmman AH, et al.
Publicado: (2017)

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA
por: M. M. Bikbov, et al.
Publicado: (2016)

Comparing the Efficacy of Intralesional Triamcinolone Acetonide With Verapamil in Treatment of Keloids: A Randomized Controlled Trial
por: Nasrin Saki, et al.
Publicado: (2019)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
por: Takeyama M, et al.
Publicado: (2017)

Aqueous angiopoietin-like levels correlate with optical coherence tomography angiography metrics in diabetic macular edema
por: Jie Yan, et al.
Publicado: (2021)

Diagnostic Criteria for Macular Edema Associated with Venous Occlusions
por: A. G. Shchuko, et al.
Publicado: (2020)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas BJ, et al.
Publicado: (2016)

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
por: Kulikov AN, et al.
Publicado: (2017)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
por: Joshi L, et al.
Publicado: (2016)

Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
por: Sheu SJ, et al.
Publicado: (2018)

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
por: Taylor K, et al.
Publicado: (2020)